Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane weekly in first-line metastatic breast cancer
NCT00251472Phase 2Completed
- Sponsor
- Veeda Lifesciences
- Start
- Mar 2005
- Primary completion
- May 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in breast cancer, sponsored by Veeda Lifesciences. Primary endpoint: Response Rate. Started Mar 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00251472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251472.